Ferrer: The Polypill Reduces Cardiovascular Mortality by 33%

The polypill developed by the CNIC and Ferrer, which includes three drugs (aspirin, an angiotensin-converting enzyme (ACE) inhibitor, and a statin), is effective at preventing secondary adverse cardiovascular

Related Keywords

Germany , Hungary , Italy , Czech Republic , Poland , France , Spain , Barcelona , Comunidad Autonoma De Cataluna , Spanish , Coll Cardiol , Jordi Bardajil , European Union Horizon , Spanish National Center , Cardiovascular Research , European Union , European Society Of Cardiology , Business Development , Mount Sinai Heart , Mount Sinai Hospital , Hot Line , European Society , New England Journal , Chief Marketing , Market Access , Business Development Officer , Secondary Cardiovascular Prevention Castellano , England Journal , Ferrer , Polypill , Educes , Ardiovascular , Ortality , Patients , Reated , After , Myocardial , Infarction ,